Amoun's Scientific Office in Egypt: Advancing Healthcare through Innovation and Expertise
- Address: EL-Obour city- Cairo- Egypt.
- Tel.:02-2610-0333.
- Tel.: 02-2610-1110.
- Fax.: 02-261-04-300.
Amoun Pharmaceutical Company S.A.E., an
Egyptian "closed" Joint-Stock Company established in 1998, has
emerged as a key player in the pharmaceutical industry. With a focus on
development, manufacturing, marketing, distribution, and export of a wide range
of human pharmaceutical and animal health products, Amoun has made significant
contributions to healthcare in Egypt. This blog post delves into the role of
Amoun's scientific office located in El Obour city, Cairo, highlighting its
contributions to innovation, product development, and ensuring the highest
standards of quality in the industry.
A Diverse
Portfolio of Pharmaceutical Products:
Amoun's core business revolves around offering
a comprehensive range of pharmaceutical products for both humans and animals.
Their extensive portfolio covers various therapeutic areas, encompassing more
than 264 different pharmaceutical forms and concentrations. These include
capsules, tablets, dry syrups, powders, effervescents, syrups, solutions,
drops, creams, suppositories, sprays, as well as sterile products like
ampoules, vials, sterile eye drops, and eye ointments. Amoun's commitment to
producing diverse pharmaceutical offerings reflects their dedication to meeting
the evolving healthcare needs of the Egyptian population.
Embracing
Innovation and Expertise:
The scientific office of Amoun in El Obour city
serves as a hub for research, development, and innovation. By harnessing the
latest advancements in pharmaceutical technologies and scientific expertise,
Amoun continuously strives to bring innovative solutions to the market. Through
their research initiatives, they aim to develop new formulations, enhance the
efficacy of existing products, and address unmet medical needs. This commitment
to innovation enables Amoun to stay at the forefront of the pharmaceutical
industry, ensuring that patients have access to high-quality, effective
medications.
Quality
Assurance and Regulatory Compliance:
Amoun places a strong emphasis on maintaining
the highest standards of quality assurance and regulatory compliance. Their
scientific office plays a vital role in ensuring that all products meet
stringent quality requirements and comply with local and international
regulations. By adhering to Good Manufacturing Practices (GMP) and stringent quality
control processes, Amoun guarantees the safety, efficacy, and reliability of
their pharmaceutical products. Through their unwavering commitment to quality,
Amoun instills confidence in healthcare professionals and patients alike.
Strategic
Partnerships and Acquisitions:
In March 2021, ADQ, one of the region's largest
holding companies, announced its definitive agreement to acquire Amoun
Pharmaceutical Company S.A.E. This strategic partnership will provide Amoun
with increased resources and support to further expand its operations, enhance
its manufacturing capabilities, and drive innovation. The acquisition by ADQ
reflects the recognition of Amoun's potential and its pivotal role in shaping
the pharmaceutical landscape in Egypt. With this partnership, Amoun is
well-positioned to continue its trajectory of growth and deliver even greater
value to the healthcare sector.
Conclusion:
Amoun's scientific office in Egypt serves as a
catalyst for innovation, research, and development in the pharmaceutical industry.
By leveraging their scientific expertise and embracing the latest technologies,
Amoun consistently delivers a diverse portfolio of pharmaceutical products that
cater to the evolving healthcare needs of the Egyptian population. Through
their commitment to quality assurance, regulatory compliance, and strategic
partnerships, Amoun remains a trusted name in the industry. Moving forward,
Amoun's scientific office will continue to drive advancements in healthcare,
ensuring that patients have access to safe, effective, and innovative
medications.
Sources:
1.
Amoun Pharmaceutical Company -
Human pharmaceutical. https://www.amoun.com/.
2.
Amoun Pharmaceutical Industries
Company | LinkedIn. https://www.linkedin.com/company/amoun-pharmaceutical-industries-company.
3.
Products - Amoun. https://www.amoun.com/products/.
4.
Amoun Pharmaceutical Company -
Company Overview. https://www.amoun.com/company-overview/.
5.
UAE’s ADQ to acquire Egypt’s
Amoun Pharmaceutical Company. https://gulfnews.com/business/uaes-adq-to-acquire-egypts-amoun-pharmaceutical-company-1.1617193794701.
6.
Amoun Pharmaceutical Company -
Leadership Team. https://www.amoun.com/leadership-team/.
7.
Amoun Pharmaceutical Company -
Board Of Directors. https://www.amoun.com/board-of-directors/.
Accuracy of information
عن الكاتب
الدكتور أحمد باكر، دكتور صيدلة
صيدلي أول ومثقف صحي بخبرة واسعة. يهدف الدكتور أحمد إلى تقديم معلومات صحية موثوقة تستند إلى الأدلة العلمية وتبسيط المفاهيم الطبية للجميع.
إخلاء المسؤولية القانونية
المعلومات المقدمة هي لأغراض تعليمية فقط ولا تغني عن استشارة الطبيب المختص.
تعليقات
إرسال تعليق